IQVIA Holdings, Inc.'s (NYSE: IQV) attempt to acquire DeepIntent, a healthcare advertising firm, was reportedly thwarted as a U.S. court upheld a Federal Trade Commission (FTC) order, citing concerns that the merger could potentially harm competition.
The FTC expressed concern that the merger would adversely impact competition, resulting in heightened consumer prices and detrimentally affecting patients, Reuters reported.
In 2022, DeepIntent, a healthcare advertising firm owned by Propel Media, a digital advertising company, forged an agreement with IQVIA to ...